Acomplia (Rimonabant), the new age weight loss drug is developed by world's third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese population across the world.
This weight loss drug
Rimonabant Acomplia works differently to most other weight loss drugs. Acomplia (Rimonabant) works in an entirely different way, by blocking CB1 a "pleasure center" in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Sanofi Clinical research showst it also might help people quit smoking as well. Zimulti Acomplia is also available in USA with prescription. Obesity is the major cause of many threating diseases like high blood pressure, increase in cholestrol or cardiovascular diseases and many other such conditions which is spreading its shadows on the world.
Acomplia Rimonabant is proved as one of the best diet pill to fight against obesity and relieve you from this all these conditions which can prove threating to your life. Purchase Acomplia Rimonabant or Zimulti online and kick the obesity to live life a king size.
So, this diet pill Acomplia Rimonabant is also known as Miracle drug as it helps people to lose weight and acts as Anti-Munchie Drug. Rimonabant is approved by European union for sale and is being sold in the United Kingdom by Sanofi-aventis under the trade name Acomplia. FDA approval has been delayed until the second half of 2006.
If you take this weight loss drug, Acomplia (Rimonabant), you will automatically eat less because your hunger will be turned off. And when you start losing weight, the first place you will lose body fat is your mid-section. The pounds will just melt away. And better yet, your cholesterol will go down and your blood pressure will return to healthy levels.
Acomplia Rimonabant (Zimulti) is recommend to those patients (BMI ≥ 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia.Rimonabant also has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking.
